{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:16:36Z","timestamp":1793970996530,"version":"4.8.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00216-023-04631-9","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T09:04:04Z","timestamp":1678093444000},"page":"4003-4021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Advances in sample preparation and HPLC\u2013MS\/MS methods for determining amyloid-\u03b2 peptide in biological samples: a review"],"prefix":"10.1007","volume":"415","author":[{"given":"Israel Donizeti","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eug\u00eania Costa","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"4631_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/gps.3829","volume":"28","author":"MS Henry","year":"2013","unstructured":"Henry MS, Passmore AP, Todd S, McGuinness B, Craig D, Johnston JA. The development of effective biomarkers for Alzheimer\u2019s disease: a review. Int J Geriatr Psychiatry. 2013;28:331\u201340. https:\/\/doi.org\/10.1002\/gps.3829.","journal-title":"Int J Geriatr Psychiatry"},{"key":"4631_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0250-2","volume":"51","author":"JC Lee","year":"2019","unstructured":"Lee JC, Kim SJ, Hong S, Kim Y. Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers. Exp Mol Med. 2019;51:1\u201310. https:\/\/doi.org\/10.1038\/s12276-019-0250-2.","journal-title":"Exp Mol Med"},{"key":"4631_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120:885\u201390. https:\/\/doi.org\/10.1016\/S0006-291X(84)80190-4.","journal-title":"Biochem Biophys Res Commun"},{"key":"4631_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/1567205016666190517121140","volume":"16","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Far\u00edas GA, Fuentes P, Navarrete LP. Biomarkers for Alzheimer\u2019s disease. Curr Alzheimer Res. 2019;16:518\u201328. https:\/\/doi.org\/10.2174\/1567205016666190517121140.","journal-title":"Curr Alzheimer Res"},{"key":"4631_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1136\/jnnp-2021-327370","volume":"92","author":"JR Chong","year":"2021","unstructured":"Chong JR, Ashton NJ, Karikari TK, Tanaka T, Sch\u00f6ll M, Zetterberg H, Blennow K, Chen CP, Lai MKP. Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer\u2019s disease: a focused review on recent advances. J Neurol Neurosurg Psychiatry. 2021;92:1231\u201341. https:\/\/doi.org\/10.1136\/jnnp-2021-327370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4631_CR6","doi-asserted-by":"publisher","unstructured":"Souza ID, Anderson JL, Queiroz MEC. Crosslinked zwitterionic polymeric ionic liquid-functionalized nitinol wires for fiber-in-tube solid-phase microextraction and UHPLC-MS\/MS as an amyloid beta peptide binding protein assay in biological fluids. Anal Chim Acta. 2022; 1193:339394. https:\/\/doi.org\/10.1016\/j.aca.2021.339394.","DOI":"10.1016\/j.aca.2021.339394."},{"key":"4631_CR7","doi-asserted-by":"publisher","unstructured":"Bros P, Delatour V, Vialaret J, Lalere B, Barthelemy N, Gabelle A, Lehmann S, Hirtz C. Quantitative detection of amyloid-\u03b2 peptides by mass spectrometry: state of the art and clinical applications. Clin Chem Lab Med. 2015;53. https:\/\/doi.org\/10.1515\/cclm-2014-1048.","DOI":"10.1515\/cclm-2014-1048."},{"key":"4631_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/14789450.2018.1525296","volume":"15","author":"NV Zakharova","year":"2018","unstructured":"Zakharova NV, Bugrova AE, Kononikhin AS, Indeykina MI, Popov IA, Nikolaev EN. Mass spectrometry analysis of the diversity of A\u03b2 peptides: difficulties and future perspectives for AD biomarker discovery. Exp Rev Proteomics. 2018;15:773\u20135. https:\/\/doi.org\/10.1080\/14789450.2018.1525296.","journal-title":"Exp Rev Proteomics"},{"key":"4631_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","volume":"136","author":"JL Molinuevo","year":"2018","unstructured":"Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, Fagan AM, Hampel H, Mielke MM, Mikulskis A, O\u2019Bryant S, Scheltens P, Sevigny J, Shaw LM, Soares HD, Tong G, Trojanowski JQ, Zetterberg H, Blennow K. Current state of Alzheimer\u2019s fluid biomarkers. Acta Neuropathol. 2018;136:821\u201353. https:\/\/doi.org\/10.1007\/s00401-018-1932-x.","journal-title":"Acta Neuropathol"},{"key":"4631_CR10","doi-asserted-by":"publisher","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","volume":"2","author":"T Saido","year":"2012","unstructured":"Saido T, Leissring MA. Proteolytic degradation of amyloid-protein. Cold Spring Harb Perspect Med. 2012;2:a006379\u2013a006379. https:\/\/doi.org\/10.1101\/cshperspect.a006379.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4631_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A\u03b2 monoclonals: evidence that an initially deposited species is A\u03b242(43). Neuron. 1994;13:45\u201353. https:\/\/doi.org\/10.1016\/0896-6273(94)90458-8.","journal-title":"Neuron"},{"key":"4631_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jalz.2013.04.506","volume":"10","author":"S Lista","year":"2014","unstructured":"Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H. CSF A\u03b21-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2014;10:381\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2013.04.506.","journal-title":"Alzheimer\u2019s Dement"},{"key":"4631_CR13","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, Bullido MJ, Engelborghs S, De Deyn P, Berr C, Pasquier F, Dubois B, Tognoni G, Fi\u00e9vet N, Brouwers N, Bettens K, Arosio B, Coto E, Del Zompo M, Mateo I, Epelbaum J, Frank-Garcia A, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Valdivieso F, Veps\u00e4l\u00e4inen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Boss\u00f9 P, Hanon O, Piccardi P, Annoni G, Seripa D, Galimberti D, Licastro F, Soininen H, Dartigues J-F, Kamboh MI, Van Broeckhoven C, Lambert JC, Amouyel P, Campion D. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011;16:903\u20137. https:\/\/doi.org\/10.1038\/mp.2011.52.","journal-title":"Mol Psychiatry"},{"key":"4631_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","volume":"167","author":"JA Soria Lopez","year":"2019","unstructured":"Soria Lopez JA, Gonz\u00e1lez HM, L\u00e9ger GC. Alzheimer\u2019s disease. Handb Clin Neurol. 2019;167:231\u201355. https:\/\/doi.org\/10.1016\/B978-0-12-804766-8.00013-3.","journal-title":"Handb Clin Neurol"},{"key":"4631_CR15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/nature08890","volume":"464","author":"A de Calignon","year":"2010","unstructured":"de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones TL, Hyman BT. Caspase activation precedes and leads to tangles. Nature. 2010;464:1201\u20134. https:\/\/doi.org\/10.1038\/nature08890.","journal-title":"Nature"},{"key":"4631_CR16","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/NEN.0b013e31817275c7","volume":"67","author":"G Basurto-Islas","year":"2008","unstructured":"Basurto-Islas G, Luna-Mu\u00f1oz J, Guillozet-Bongaarts AL, Binder LI, Mena R, Garc\u00eda-Sierra F. Accumulation of aspartic acid 421 - and glutamic acid 391 - cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J Neuropathol Exp Neurol. 2008;67:470\u201383. https:\/\/doi.org\/10.1097\/NEN.0b013e31817275c7.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4631_CR17","doi-asserted-by":"publisher","unstructured":"Alonso A del C, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K. Hyperphosphorylation induces self-assembly of \u03c4 into tangles of paired helical filaments\/straight filaments. Proc Natl Acad Sci. 2001;98:6923\u20136928. https:\/\/doi.org\/10.1073\/pnas.121119298.","DOI":"10.1073\/pnas.121119298"},{"key":"4631_CR18","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1093\/brain\/aww224","volume":"139","author":"BD James","year":"2016","unstructured":"James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA. TDP-43 stage, mixed pathologies, and clinical Alzheimer\u2019s-type dementia. Brain. 2016;139:2983\u201393. https:\/\/doi.org\/10.1093\/brain\/aww224.","journal-title":"Brain"},{"key":"4631_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00401-013-1157-y","volume":"126","author":"GG Kovacs","year":"2013","unstructured":"Kovacs GG, Milenkovic I, W\u00f6hrer A, H\u00f6ftberger R, Gelpi E, Haberler C, H\u00f6nigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth S, Krampla W, Fischer P, Budka H. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol. 2013;126:365\u201384. https:\/\/doi.org\/10.1007\/s00401-013-1157-y.","journal-title":"Acta Neuropathol"},{"key":"4631_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Elliott C, Masliah E, Ryan L, Silverberg N. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2018;14:535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimer\u2019s Dement"},{"key":"4631_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P. Advantages and disadvantages of the use of the CSF amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11:34. https:\/\/doi.org\/10.1186\/s13195-019-0485-0.","journal-title":"Alzheimers Res Ther"},{"key":"4631_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/acn3.274","volume":"3","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Zetterberg H, Mattsson N, Palmqvist S, Vanderstichele H, Lindberg O, Westen D, Stomrud E, Minthon L, Blennow K, Hansson O. CSF A\u03b242\/A\u03b240 and A\u03b242\/A\u03b238 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol. 2016;3:154\u201365. https:\/\/doi.org\/10.1002\/acn3.274.","journal-title":"Ann Clin Transl Neurol"},{"key":"4631_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","volume":"13","author":"V Ovod","year":"2017","unstructured":"Ovod V, Ramsey KN, Mawuenyega KG, Bollinger JG, Hicks T, Schneider T, Sullivan M, Paumier K, Holtzman DM, Morris JC, Benzinger T, Fagan AM, Patterson BW, Bateman RJ. Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimer\u2019s Dement. 2017;13:841\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2017.06.2266.","journal-title":"Alzheimer\u2019s Dement"},{"key":"4631_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3233\/JAD-132489","volume":"41","author":"M Korecka","year":"2014","unstructured":"Korecka M, Waligorska T, Figurski M, Toledo JB, Arnold SE, Grossman M, Trojanowski JQ, Shaw LM. Qualification of a surrogate matrix-based absolute quantification method for amyloid-\u03b242 in Human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry. J Alzheimer\u2019s Dis. 2014;41:441\u201351. https:\/\/doi.org\/10.3233\/JAD-132489.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"4631_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1373\/clinchem.2013.220392","volume":"60","author":"A Leinenbach","year":"2014","unstructured":"Leinenbach A, Pannee J, D\u00fclffer T, Huber A, Bittner T, Andreasson U, Gobom J, Zetterberg H, Kobold U, Portelius E, Blennow K. Mass spectrometry\u2013based candidate reference measurement procedure for quantification of amyloid-\u03b2 in cerebrospinal fluid. Clin Chem. 2014;60:987\u201394. https:\/\/doi.org\/10.1373\/clinchem.2013.220392.","journal-title":"Clin Chem"},{"key":"4631_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/brain\/awaa403","volume":"144","author":"A Keshavan","year":"2021","unstructured":"Keshavan A, Pannee J, Karikari T, Rodriguez J, Ashton N, Nicholas J, Cash D, Coath W, Lane C, Parker T, Lu K, Buchanan S, Keuss S, James S, Murray-Smith H, Wong A, Barnes A, Dickson J, Heslegrave A, Portelius E, Richards M, Fox N, Zetterberg H, Blennow K, Schott J. Population-based blood screening for preclinical Alzheimer\u2019s disease in a British birth cohort at age 70. Brain. 2021;144:434\u201349. https:\/\/doi.org\/10.1093\/brain\/awaa403.","journal-title":"Brain"},{"key":"4631_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/jalm\/jfaa225","volume":"6","author":"T Iino","year":"2021","unstructured":"Iino T, Watanabe S, Yamashita K, Tamada E, Hasegawa T, Irino Y, Iwanaga S, Harada A, Noda K, Suto K, Yoshida T. Quantification of amyloid-\u03b2 in plasma by simple and highly sensitive immunoaffinity enrichment and LC-MS\/MS assay. J Appl Lab Med. 2021;6:834\u201345. https:\/\/doi.org\/10.1093\/jalm\/jfaa225.","journal-title":"J Appl Lab Med"},{"key":"4631_CR28","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1039\/C9AN00751B","volume":"144","author":"A Viod\u00e9","year":"2019","unstructured":"Viod\u00e9 A, Epelbaum S, Benyounes I, Verny M, Dubois B, Junot C, Fenaille F, Lamari F, Becher F. Simultaneous quantification of tau and \u03b1-synuclein in cerebrospinal fluid by high-resolution mass spectrometry for differentiation of Lewy body dementia from Alzheimer\u2019s disease and controls. Analyst. 2019;144:6342\u201351. https:\/\/doi.org\/10.1039\/C9AN00751B.","journal-title":"Analyst"},{"key":"4631_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13195-017-0276-4","volume":"9","author":"D Chiasserini","year":"2017","unstructured":"Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L. Differential role of CSF fatty acid binding protein 3, \u03b1-synuclein, and Alzheimer\u2019s disease core biomarkers in Lewy body disorders and Alzheimer\u2019s dementia. Alzheimers Res Ther. 2017;9:52. https:\/\/doi.org\/10.1186\/s13195-017-0276-4.","journal-title":"Alzheimers Res Ther"},{"key":"4631_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00415-014-7334-7","volume":"261","author":"T Kasai","year":"2014","unstructured":"Kasai T, Tokuda T, Ishii R, Ishigami N, Tsuboi Y, Nakagawa M, Mizuno T, El-Agnaf OMA. Increased \u03b1-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol. 2014;261:1203\u20139. https:\/\/doi.org\/10.1007\/s00415-014-7334-7.","journal-title":"J Neurol"},{"key":"4631_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-220425","volume":"89","author":"Y Kong","year":"2022","unstructured":"Kong Y, Chen Z, Wang X, Wang W, Zhang J. Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Creutzfeldt-Jakob disease: a systematic review and meta-analysis. J Alzheimer\u2019s Dis. 2022;89:493\u2013503. https:\/\/doi.org\/10.3233\/JAD-220425.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"4631_CR32","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s00216-011-5648-1","volume":"402","author":"K Watanabe","year":"2012","unstructured":"Watanabe K, Ishikawa C, Kuwahara H, Sato K, Komuro S, Nakagawa T, Nomura N, Watanabe S, Yabuki M. A new methodology for simultaneous quantification of total-A\u03b2, A\u03b2x-38, A\u03b2x-40, and A\u03b2x-42 by column-switching LC\/MS\/MS. Anal Bioanal Chem. 2012;402:2033\u201342. https:\/\/doi.org\/10.1007\/s00216-011-5648-1.","journal-title":"Anal Bioanal Chem"},{"key":"4631_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jchromb.2017.10.047","volume":"1070","author":"P Lin","year":"2017","unstructured":"Lin P, Chen W, Yuan F, Sheng L, Wu Y, Zhang W, Li G, Xu H, Li X. An UHPLC\u2013MS\/MS method for simultaneous quantification of human amyloid beta peptides A\u03b21-38, A\u03b21-40 and A\u03b21-42 in cerebrospinal fluid using micro-elution solid phase extraction. J Chromatogr B. 2017;1070:82\u201391. https:\/\/doi.org\/10.1016\/j.jchromb.2017.10.047.","journal-title":"J Chromatogr B"},{"key":"4631_CR34","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jalz.2018.05.008","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H, Molinuevo JL, Shaw LM, Vandijck M, Verbeek MM, Savage M, Mattsson N, Lewczuk P, Batrla R, Rutz S, Dean RA, Blennow K. The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer\u2019s disease diagnosis: a review. Alzheimer\u2019s Dement. 2018;14:1313\u201333. https:\/\/doi.org\/10.1016\/j.jalz.2018.05.008.","journal-title":"Alzheimer\u2019s Dement"},{"key":"4631_CR35","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2021-0549","author":"LM Forgrave","year":"2021","unstructured":"Forgrave LM, van der Gugten JG, Nguyen Q, DeMarco ML. Establishing pre-analytical requirements and maximizing peptide recovery in the analytical phase for mass spectrometric quantification of amyloid-\u03b2 peptides 1\u201342 and 1\u201340 in CSF. Clin Chem Lab Med. 2021. https:\/\/doi.org\/10.1515\/cclm-2021-0549.","journal-title":"Clin Chem Lab Med"},{"key":"4631_CR36","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1002\/rcm.2787","volume":"20","author":"T Oe","year":"2006","unstructured":"Oe T, Ackermann BL, Inoue K, Berna MJ, Garner CO, Gelfanova V, Dean RA, Siemers ER, Holtzman DM, Farlow MR, Blair IA. Quantitative analysis of amyloid\u03b2 peptides in cerebrospinal fluid of Alzheimer\u2019s disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography\/negative electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2006;20:3723\u201335. https:\/\/doi.org\/10.1002\/rcm.2787.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"4631_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dor\u00e9 V, Fowler C, Li Q-X, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, Iwamoto S, Ito K, Tanaka K, Masters CL, Yanagisawa K. High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature. 2018;554:249\u201354. https:\/\/doi.org\/10.1038\/nature25456.","journal-title":"Nature"},{"key":"4631_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ab.2013.04.031","volume":"440","author":"KG Mawuenyega","year":"2013","unstructured":"Mawuenyega KG, Kasten T, Sigurdson W, Bateman RJ. Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics. Anal Biochem. 2013;440:56\u201362. https:\/\/doi.org\/10.1016\/j.ab.2013.04.031.","journal-title":"Anal Biochem"},{"key":"4631_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2183\/pjab.90.104","volume":"90","author":"N Kaneko","year":"2014","unstructured":"Kaneko N, Yamamoto R, Sato T-A, Tanaka K. Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry. Proc Japan Acad Ser B. 2014;90:104\u201317. https:\/\/doi.org\/10.2183\/pjab.90.104.","journal-title":"Proc Japan Acad Ser B"},{"key":"4631_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cca.2021.05.011","volume":"519","author":"KM Kirmess","year":"2021","unstructured":"Kirmess KM, Meyer MR, Holubasch MS, Knapik SS, Hu Y, Jackson EN, Harpstrite SE, Verghese PB, West T, Fogelman I, Braunstein JB, Yarasheski KE, Contois JH. The PrecivityAD\u2122 test: accurate and reliable LC-MS\/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis. Clin Chim Acta. 2021;519:267\u201375. https:\/\/doi.org\/10.1016\/j.cca.2021.05.011.","journal-title":"Clin Chim Acta"},{"key":"4631_CR41","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s12010-015-1837-2","volume":"177","author":"Y Shimazaki","year":"2015","unstructured":"Shimazaki Y, Takatsu Y. Combined method of immunoaffinity membrane within tubes and MALDI-TOF MS for capturing and analyzing amyloid beta. Appl Biochem Biotechnol. 2015;177:1565\u201371. https:\/\/doi.org\/10.1007\/s12010-015-1837-2.","journal-title":"Appl Biochem Biotechnol"},{"key":"4631_CR42","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, Holtzman DM, Morris JC, Benzinger TLS, Xiong C, Fagan AM, Bateman RJ. High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology. 2019;93:e1647\u201359. https:\/\/doi.org\/10.1212\/WNL.0000000000008081.","journal-title":"Neurology"},{"key":"4631_CR43","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3233\/JAD-200987","volume":"79","author":"Y Seino","year":"2021","unstructured":"Seino Y, Nakamura T, Harada T, Nakahata N, Kawarabayashi T, Ueda T, Takatama M, Shoji M. Quantitative measurement of cerebrospinal fluid amyloid-\u03b2 species by mass spectrometry. J Alzheimer\u2019s Dis. 2021;79:573\u201384. https:\/\/doi.org\/10.3233\/JAD-200987.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"4631_CR44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/jnc.13838","volume":"139","author":"J Pannee","year":"2016","unstructured":"Pannee J, Portelius E, Minthon L, Gobom J, Andreasson U, Zetterberg H, Hansson O, Blennow K. Reference measurement procedure for CSF amyloid beta (A\u03b2) 1\u201342 and the CSF A\u03b2 1\u201342 \/A\u03b2 1\u201340 ratio - a cross-validation study against amyloid PET. J Neurochem. 2016;139:651\u20138. https:\/\/doi.org\/10.1111\/jnc.13838.","journal-title":"J Neurochem"},{"key":"4631_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s12272-013-0215-2","volume":"37","author":"YG Shin","year":"2014","unstructured":"Shin YG, Hamm L, Murakami S, Buirst K, Buonarati MH, Cox A, Regal K, Hunt KW, Scearce-Levie K, Watts RJ, Liu X. Qualification and application of a liquid chromatography\u2013tandem mass spectrometric method for the determination of human A\u03b21-40 and A\u03b21-42 peptides in transgenic mouse plasma using micro-elution solid phase extraction. Arch Pharm Res. 2014;37:636\u201344. https:\/\/doi.org\/10.1007\/s12272-013-0215-2.","journal-title":"Arch Pharm Res"},{"key":"4631_CR46","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3233\/JAD-2012-121471","volume":"33","author":"J Pannee","year":"2013","unstructured":"Pannee J, Portelius E, Oppermann M, Atkins A, Hornshaw M, Zegers I, H\u00f6jrup P, Minthon L, Hansson O, Zetterberg H, Blennow K, Gobom J. A selected reaction monitoring (SRM)-based method for absolute quantification of A\u03b238, A\u03b240, and A\u03b242 in cerebrospinal fluid of Alzheimer\u2019s disease patients and healthy controls. J Alzheimers Dis. 2013;33:1021\u201332. https:\/\/doi.org\/10.3233\/JAD-2012-121471.","journal-title":"J Alzheimers Dis"},{"key":"4631_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ab.2011.08.010","volume":"419","author":"ME Lame","year":"2011","unstructured":"Lame ME, Chambers EE, Blatnik M. Quantitation of amyloid beta peptides A\u03b21\u201338, A\u03b21\u201340, and A\u03b21\u201342 in human cerebrospinal fluid by ultra-performance liquid chromatography\u2013tandem mass spectrometry. Anal Biochem. 2011;419:133\u20139. https:\/\/doi.org\/10.1016\/j.ab.2011.08.010.","journal-title":"Anal Biochem"},{"key":"4631_CR48","doi-asserted-by":"publisher","unstructured":"Souza ID, Anderson JL, Tumas V, Queiroz MEC. Direct coupling of fiber-in-tube solid-phase microextraction with tandem mass spectrometry to determine amyloid beta peptides as biomarkers for Alzheimer\u2019s disease in cerebrospinal fluid samples. Talanta. 2023;254:124186. https:\/\/doi.org\/10.1016\/j.talanta.2022.124186.","DOI":"10.1016\/j.talanta.2022.124186."},{"key":"4631_CR49","doi-asserted-by":"publisher","first-page":"31894","DOI":"10.1074\/jbc.271.50.31894","volume":"271","author":"R Wang","year":"1996","unstructured":"Wang R, Sweeney D, Gandy SE, Sisodia SS. The profile of soluble amyloid \u03b2 protein in cultured cell media. J Biol Chem. 1996;271:31894\u2013902. https:\/\/doi.org\/10.1074\/jbc.271.50.31894.","journal-title":"J Biol Chem"},{"key":"4631_CR50","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/j.1471-4159.1993.tb09841.x","volume":"61","author":"C Vigo-Pelfrey","year":"1993","unstructured":"Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB. Rapid communication: characterization of \u03b2-amyloid peptide from human cerebrospinal fluid. J Neurochem. 1993;61:1965\u20138. https:\/\/doi.org\/10.1111\/j.1471-4159.1993.tb09841.x.","journal-title":"J Neurochem"},{"key":"4631_CR51","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/rcm.1048","volume":"17","author":"P Lewczuk","year":"2003","unstructured":"Lewczuk P, Esselmann H, Meyer M, Wollscheid V, Neumann M, Otto M, Maler JM, R\u00fcther E, Kornhuber J, Wiltfang J. The amyloid-\u03b2 (A\u03b2 ) peptide pattern in cerebrospinal fluid in Alzheimer\u2019s disease: evidence of a novel carboxyterminally elongated A \u03b2 peptide. Rapid Commun Mass Spectrom. 2003;17:1291\u20136. https:\/\/doi.org\/10.1002\/rcm.1048.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"4631_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000080991","volume":"1","author":"AS Maddalena","year":"2004","unstructured":"Maddalena AS, Papassotiropoulos A, Gonzalez-Agosti C, Signorell A, Hegi T, Pasch T, Nitsch RM, Hock C. Cerebrospinal fluid profile of amyloid \u03b2 peptides in patients with Alzheimer\u2019s disease determined by protein biochip technology. Neurodegener Dis. 2004;1:231\u20135. https:\/\/doi.org\/10.1159\/000080991.","journal-title":"Neurodegener Dis"},{"key":"4631_CR53","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1021\/pr050475v","volume":"5","author":"E Portelius","year":"2006","unstructured":"Portelius E, Westman-Brinkmalm A, Zetterberg H, Blennow K. Determination of \u03b2-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry. J Proteome Res. 2006;5:1010\u20136. https:\/\/doi.org\/10.1021\/pr050475v.","journal-title":"J Proteome Res"},{"key":"4631_CR54","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1021\/pr0703627","volume":"6","author":"E Portelius","year":"2007","unstructured":"Portelius E, Tran AJ, Andreasson U, Persson R, Brinkmalm G, Zetterberg H, Blennow K, Westman-Brinkmalm A. Characterization of amyloid \u03b2 peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. J Proteome Res. 2007;6:4433\u20139. https:\/\/doi.org\/10.1021\/pr0703627.","journal-title":"J Proteome Res"},{"key":"4631_CR55","doi-asserted-by":"publisher","unstructured":"Yu J, Di S, Yu H, Ning T, Yang H, Zhu S. Insights into the structure-performance relationships of extraction materials in sample preparation for chromatography. J Chromatogr A. 2021;1637:461822. https:\/\/doi.org\/10.1016\/j.chroma.2020.461822.","DOI":"10.1016\/j.chroma.2020.461822."},{"key":"4631_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF02491931","volume":"56","author":"NC Dias","year":"2002","unstructured":"Dias NC, Poole CF. Mechanistic study of the sorption properties of OASIS\u00ae HLB and its use in solid-phase extraction. Chromatographia. 2002;56:269\u201375. https:\/\/doi.org\/10.1007\/BF02491931.","journal-title":"Chromatographia"},{"key":"4631_CR57","unstructured":"Salcedo J, Lambert P, Davey L, Lame ME, Dunning C, Chambers EE. Amyloid beta peptides quantification by SPE-LC-MS\/MS with automated sample preparation for preclinical research and biomarker discovery. Waters\u00ae Application Note. 2019;1\u20137."},{"key":"4631_CR58","doi-asserted-by":"publisher","unstructured":"Souza ID, Oliveira IGC, Queiroz MEC Innovative extraction materials for fiber-in-tube solid phase microextraction: a review. Anal Chim Acta. 2021; 1165:238110. https:\/\/doi.org\/10.1016\/j.aca.2020.11.042.","DOI":"10.1016\/j.aca.2020.11.042."},{"key":"4631_CR59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/05704920902717872","volume":"44","author":"A El-Aneed","year":"2009","unstructured":"El-Aneed A, Cohen A, Banoub J. Mass spectrometry, review of the basics: electrospray, MALDI, and commonly used mass analyzers. Appl Spectrosc Rev. 2009;44:210\u201330. https:\/\/doi.org\/10.1080\/05704920902717872.","journal-title":"Appl Spectrosc Rev"},{"key":"4631_CR60","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/S0021-9258(18)53661-9","volume":"268","author":"AE Roher","year":"1993","unstructured":"Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Z\u00fcrcher-Neely HA, Heinrikson RL, Ball MJ. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer\u2019s disease. J Biol Chem. 1993;268:3072\u201383. https:\/\/doi.org\/10.1016\/S0021-9258(18)53661-9.","journal-title":"J Biol Chem"},{"key":"4631_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/abbi.1993.1112","volume":"301","author":"DL Miller","year":"1993","unstructured":"Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer\u2032s disease. Arch Biochem Biophys. 1993;301:41\u201352. https:\/\/doi.org\/10.1006\/abbi.1993.1112.","journal-title":"Arch Biochem Biophys"},{"key":"4631_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4155\/bio.10.163","volume":"3","author":"L Dillen","year":"2011","unstructured":"Dillen L, Cools W, Vereyken L, Timmerman P. A screening UHPLC\u2013MS\/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species. Bioanalysis. 2011;3:45\u201355. https:\/\/doi.org\/10.4155\/bio.10.163.","journal-title":"Bioanalysis"},{"key":"4631_CR63","unstructured":"Chambers EE, Lame ME, Diehl DM. An improved SPE-LC\u2013MS\u2013MS platform for the simultaneous quantification of multiple amyloid beta peptides in cerebrospinal fluid for preclinical or biomarker discovery. In: LCGC Asia Pacific; 2011."},{"key":"4631_CR64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jalz.2015.06.1890","volume":"12","author":"J Pannee","year":"2016","unstructured":"Pannee J, Gobom J, Shaw LM, Korecka M, Chambers EE, Lame M, Jenkins R, Mylott W, Carrillo MC, Zegers I, Zetterberg H, Blennow K, Portelius E. Round robin test on quantification of amyloid-\u03b2 1\u201342 in cerebrospinal fluid by mass spectrometry. Alzheimer\u2019s Dement. 2016;12:55\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2015.06.1890.","journal-title":"Alzheimer\u2019s Dement"},{"key":"4631_CR65","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0006-291X(87)90419-0","volume":"149","author":"T Yamada","year":"1987","unstructured":"Yamada T, Sasaki H, Furuya H, Miyata T, Goto I, Sakaki Y. Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. Biochem Biophys Res Commun. 1987;149:665\u201371. https:\/\/doi.org\/10.1016\/0006-291X(87)90419-0.","journal-title":"Biochem Biophys Res Commun"},{"key":"4631_CR66","doi-asserted-by":"publisher","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","volume":"267","author":"H Mori","year":"1992","unstructured":"Mori H, Takio K, Ogawara M, Selkoe DJ. Mass spectrometry of purified amyloid beta protein in Alzheimer\u2019s disease. J Biol Chem. 1992;267:17082\u20136. https:\/\/doi.org\/10.1016\/S0021-9258(18)41896-0.","journal-title":"J Biol Chem"},{"key":"4631_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/mas.21775","author":"NV Zakharova","year":"2022","unstructured":"Zakharova NV, Kononikhin AS, Indeykina MI, Bugrova AE, Strelnikova P, Pekov S, Kozin SA, Popov IA, Mitkevich V, Makarov AA, Nikolaev EN. Mass spectrometric studies of the variety of beta-amyloid proteoforms in Alzheimer\u2019s disease. Mass Spectrom Rev. 2022. https:\/\/doi.org\/10.1002\/mas.21775.","journal-title":"Mass Spectrom Rev"},{"key":"4631_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","volume":"120","author":"E Portelius","year":"2010","unstructured":"Portelius E, Bogdanovic N, Gustavsson MK, Volkmann I, Brinkmalm G, Zetterberg H, Winblad B, Blennow K. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease. Acta Neuropathol. 2010;120:185\u201393. https:\/\/doi.org\/10.1007\/s00401-010-0690-1.","journal-title":"Acta Neuropathol"},{"key":"4631_CR69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clinbiochem.2019.05.006","volume":"72","author":"LM Shaw","year":"2019","unstructured":"Shaw LM, Hansson O, Manuilova E, Masters CL, Doecke JD, Li Q-X, Rutz S, Widmann M, Leinenbach A, Blennow K. Method comparison study of the Elecsys\u00ae \u03b2-Amyloid (1\u201342) CSF assay versus comparator assays and LC-MS\/MS. Clin Biochem. 2019;72:7\u201314. https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.05.006.","journal-title":"Clin Biochem"},{"key":"4631_CR70","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1373\/jalm.2019.030080","volume":"5","author":"MM Budelier","year":"2020","unstructured":"Budelier MM, Bateman RJ. Biomarkers of Alzheimer disease. J Appl Lab Med. 2020;5:194\u2013208. https:\/\/doi.org\/10.1373\/jalm.2019.030080.","journal-title":"J Appl Lab Med"},{"key":"4631_CR71","doi-asserted-by":"publisher","first-page":"205031211559825","DOI":"10.1177\/2050312115598250","volume":"3","author":"KB Shanthi","year":"2015","unstructured":"Shanthi KB, Krishnan S, Rani P. A systematic review and meta-analysis of plasma amyloid 1\u201342 and tau as biomarkers for Alzheimer\u2019s disease. SAGE Open Med. 2015;3:205031211559825. https:\/\/doi.org\/10.1177\/2050312115598250.","journal-title":"SAGE Open Med"},{"key":"4631_CR72","doi-asserted-by":"publisher","first-page":"26801","DOI":"10.1038\/srep26801","volume":"6","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Stomrud E, Palmqvist S, Zetterberg H, van Westen D, Jeromin A, Song L, Hanlon D, Tan Hehir CA, Baker D, Blennow K, Hansson O. Plasma \u03b2-amyloid in Alzheimer\u2019s disease and vascular disease. Sci Rep. 2016;6:26801. https:\/\/doi.org\/10.1038\/srep26801.","journal-title":"Sci Rep"},{"key":"4631_CR73","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/alz.12395","volume":"18","author":"S Janelidze","year":"2022","unstructured":"Janelidze S, Palmqvist S, Leuzy A, Stomrud E, Verberk IMW, Zetterberg H, Ashton NJ, Pesini P, Sarasa L, Allu\u00e9 JA, Teunissen CE, Dage JL, Blennow K, Mattsson-Carlgren N, Hansson O. Detecting amyloid positivity in early Alzheimer\u2019s disease using combinations of plasma A\u03b242\/A\u03b240 and p-tau. Alzheimer\u2019s Dement. 2022;18:283\u201393. https:\/\/doi.org\/10.1002\/alz.12395.","journal-title":"Alzheimer\u2019s Dement"},{"key":"4631_CR74","doi-asserted-by":"publisher","first-page":"28163","DOI":"10.1074\/jbc.C112.360800","volume":"287","author":"HF Stanyon","year":"2012","unstructured":"Stanyon HF, Viles JH. Human serum albumin can regulate amyloid-\u03b2 peptide fiber growth in the brain interstitium. J Biol Chem. 2012;287:28163\u20138. https:\/\/doi.org\/10.1074\/jbc.C112.360800.","journal-title":"J Biol Chem"},{"key":"4631_CR75","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1006\/bbrc.2000.2222","volume":"268","author":"Y-M Kuo","year":"2000","unstructured":"Kuo Y-M, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR, Roher AE. Amyloid-\u03b2 peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun. 2000;268:750\u20136. https:\/\/doi.org\/10.1006\/bbrc.2000.2222.","journal-title":"Biochem Biophys Res Commun"},{"key":"4631_CR76","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bbrc.2007.10.080","volume":"364","author":"M R\u00f3zga","year":"2007","unstructured":"R\u00f3zga M, K\u0142oniecki M, Jab\u0142onowska A, Dadlez M, Bal W. The binding constant for amyloid A\u03b240 peptide interaction with human serum albumin. Biochem Biophys Res Commun. 2007;364:714\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2007.10.080.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-023-04631-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-023-04631-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-023-04631-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T12:16:31Z","timestamp":1688732191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-023-04631-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":76,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4631"],"URL":"https:\/\/doi.org\/10.1007\/s00216-023-04631-9","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}